KBio utilizes a plant-based platform to manufacture high-quality proteins and bioactive compounds at scale, addressing the need for rapid development of therapeutics in health and medicine. This efficient process leverages strategic global partnerships to enhance the production capabilities of biologics, overcoming traditional manufacturing limitations.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional methods of producing biologics often face challenges in scalability, sustainability, and speed, hindering the rapid development and large-scale manufacturing of therapeutics and bioactive compounds needed to address urgent public health demands. Plant-based biologics have long held potential, but they are historically difficult to scale.
Solution
KBio leverages its proprietary RP3 platform, a plant-based biofoundry, to overcome the limitations of traditional biologic manufacturing. This synergistic platform uses plants to produce high-quality proteins and bioactive compounds at an unprecedented scale, enabling the rapid development and production of monoclonal antibodies (mAbs) and vaccines. By integrating agtech, nanotech, biotech, and engineering sciences, KBio offers a sustainable and scalable solution for producing therapeutics and exploring opportunities in the food and nutraceutical sectors. Through strategic global partnerships, KBio maximizes the impact of the RP3 ecosystem, bringing projects to life and addressing public health challenges.
Target Audience
KBio's primary customers are pharmaceutical companies, research institutions, and other organizations seeking rapid, scalable, and sustainable manufacturing solutions for biologics and bioactive compounds.
Features
- RP3 platform for efficient and sustainable production of plant-derived proteins
- Capability to produce monoclonal antibodies (mAbs) and vaccines
- Integration of agtech, nanotech, biotech, and engineering sciences
- Strategic partnerships to enhance development and production
- Scalable manufacturing processes for large-scale production of biomolecules
- Potential applications in therapeutics, food, and nutraceutical sectors